Evidence for nitric oxide action on in vitro granuloma formation through pivotal changes in MIP-1α and IL-10 release in human schistosomiasis

Nitric Oxide - Biology and Chemistry

Volumn 3, Issue 2, 1999, Pages 162-171

  Oliveira, Diana M ^a,b   Silva Teixeira, David N ^a   Goes, Alfredo M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b STATE UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

IL 10; In vitro granuloma; L NAME; MIP 1 ; Nitric oxide; Schistosoma mansoni

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; GRANULOMA; HUMAN; HUMAN CELL; INFLAMMATION; MONONUCLEAR CELL; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

SCHISTOSOMA MANSONI;

EID: 0032817471     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1006/niox.1999.0219     Document Type: Article

References (48)

1. Oswald I. P., Wynn T. A., Sher A., James S. L. NO as an effector molecule of parasite killing: Modulation of its synthesis by cytokines. Comp. Biochem. Physiol. Pharmacol. Toxicol. Endocrinol. 108:1994;11-18.
2. MacMicking J., Xie Q. W., Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:1997;323-350.
3. Mannick J. B., Asano K., Izumi K., Kieff E., Stamler J. S. Nitric oxide produced by human lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell. 79:1994;1137-1146.
4. Liew F. Y. Regulation of lymphocyte functions by nitric oxide. Curr. Opin. Immunol. 7:1995;396-399.
5. Kubes P., Suzuki M., Granger D. M. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA. 88:1991;4651-4655.
6. Adam A. Endogenous mediators in the acute local inflammatory process - Proteins of the acute central phase: Current data and perspectives. Rev. Med. Liege. 37:1982;852-856.
7. Camp R. D. Prostaglandins, hydroxy fatty acids, leukotrienes and inflammation of the skin. Clin. Exp. Dermatol. 7:1982;435-444.
8. Heck D. E. Molecular mechanisms regulating nitric oxide biosynthesis: Role of xenobiotics in epithelial inflammation. Adv. Exp. Med. Biol. 387:1996;171-176.
9. Feng Q., Hedner T. Endothelium-derived relaxing factor (EDRF) and nitric oxide (NO). II. Physiology, pharmacology and pathophysiological implications. Clin. Physiol. 10:1990;503-526.
10. Marletta M. A. Nitric oxide synthase structure and mechanism. J. Biol. Chem. 268:1993;12231-12234.
11. Stamler J. S., Loh E., Roddy M. A., Currie K. E., Creager M. A. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation. 89:1994;2035-2040.
12. Stadler J., Schmalix W. A., Doehmer J. Inhibition of cytochrome P450 enzymes by nitric oxide. Adv. Exp. Med. Biol. 387:1996;187-193.
13. Lucaks N. W., Kunkel S. L., Strieter R. M., Warmington K., Chensue S. W. The role of macrophage inflammatory protein 1 a inSchistosoma mansoni. J. Exp. Med. 177:1993;1551-1559.
14. Chensue S. W., Warmington K., Ruth J. H., Kukacs N., Kunkel S. L. Mycobacterial and schistosomal antigen-elicited granuloma formation in IFN-γ and IL-4 knockout mice. J. Immunol. 159:1997;3565-3573.
15. Katz N., Chaves A., Pellegrino J. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev. Inst. Med. Trop. 14:1972;397-400.
16. Thorsby G., Bratlier A. A rapid method for preparation of pure lymphocyte suspensions. Histocompatibility Testing. 1970;Williams and Wilkins, Baltimore. p. 665-677.
17. Dougthy B. L., Ottesen E. A., Nash T. E., Phillips S. M. Delayed hypersensitivity granuloma formation aroundSchistosoma mansoniin vitro. J. Immunol. 133:1984;993-997.
18. Doughty B. L., Goes A. M., Parra J. C., Rocha R. S., Katz A., Colley D. G., Gazzinelli G. Granulomatous hypersensitivity toSchistosoma mansoni. Mem. Inst. Oswaldo Cruz. 82:1987;47-51.
19. 15. Anal. Biochem. 126:1982;131-138.
20. Xiong H., Kawamura I., Nishibori T., Mitsuyama M. Suppression of IFNγ production fromListeria monocytogenes. Cell. Immunol. 172:1996;118-123.
21. SAS Introductory Guide for Personal Computers. 1990.
22. Baggiolini M., Dewald B., Moser B. Human chemokines: An update. Annu. Rev. Immunol. 15:1997;675-705.
23. Cocchi F., DeVico A. L., Garzino-Demo A., Arya S. K., Gallo R. C., Lusso P. RANTES, MIP-1α in HIV. Science. 270:1995;1811-1815.
24. Marshall J. D., Robertson S. E., Trinchieri G., Chehimi J. Priming with IL-4 and IL-13 during HIV-1 infection restores in vitro IL-12 production by mononuclear cells of HIV-infected patients. J. Immunol. 159:1997;5705-5714.
25. Mosmann T. R. Properties and functions of interleukin-10. Adv. Immunol. 56:1994;1-26.
26. Berkman N., John M., Roesems G., Jose P. J., Barnes P. J., Chung K. F. Inhibition of macrophage inflammatory protein-1a expression by IL-10. J. Immunol. 155:1995;4412-4418.
27. Maltman J., Pragnell I. B., Graham G. J. Specificity and reciprocity in the interactions between TGF-β and MIP-1α J. Immunol. 156:1996;1566-1571.
28. Drapier J. C. Nitric oxide in the cytokine network. Moncada S., Nistico G., Higgs E. A. Nitric Oxide: Brain and Immune System. 1993;205-212 Portland Press, London.
29. Tsunawaki S., Sporn M., Ding A., Nathan C. Deactivation of macrophages by transforming growth factor β Nature. 334:1988;260-263.
30. Fiorentino D. F., Zlotinik A., Mosman T. R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:1991;3815-3822.
31. Drapier J. C., Wietzerbin J., Hibbs J. B. Interferon-γ and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur. J. Immunol. 18:1988;1587-1592.
32. Wynn T. A., Morawetz R., Scharton-Kersten T., Hieny S., Morse H. C. III, Kuhn R., Muller W., Cheever A. W., Sher A. Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responsesin vivo. J. Immunol. 159:1997;5014-5023.
33. Hsieh C. S., Heimberger A. B., Gold J. S., O'Garra A., Murphy K. M. Differential regulation of T helper phenotype development by interleulin 4 and 10 in an alpha beta T-cell receptor transgenic system. Proc. Natl. Acad. Sci. USA. 89:1992;6065-6069.
34. Appleton I., Tomlinson A., Willoughby D. A. Induction of cyclo-oxygenase and nitric oxide synthase in inflammation. Adv. Pharmacol. 35:1996;27-78.
35. Cher D. J., Mosmann T. R. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by Th1 clones. J. Immunol. 138:1987;3668-3672.
36. Fong T. A., Mosman T. R. The role of IFN-γ in delayed type hypersensitivity mediated by Th1 clones. J. Immunol. 143:1989;2887-2893.
37. Scott P., Kaufmann S. H. The role of T-cell subsets and cytokines in the regulation of infection. Immunol. Today. 12:1991;346-348.
38. Chensue S. W., Warmington K. S., Ruth J. H., Lincoln P., Kuo M. C., Kunkel S. L. Cytokine responses during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation: Production of Th1 and Th2 cytokines and relative contribution of tumor necrosis factor. Am. J. Pathol. 145:1994;1105-1110.
39. Oliveira D. M., Silva-Teixeira D. N., Carmo S. A., Goes A.M. Role of nitric oxide on human schistosomiasis mansoni: Up-regulation ofin vitrol. Nitric Oxide: Biol. Chem. 2:1998;57-65.
40. Hogaboam C. M., Chensue S. W., Steinhauser M. L., Huffnagle G. B., Lukacs N. W., Strieter R. M., Kunkel S. L. Alteration of the cytokine phenotype in an experimental lung granuloma model by inhibiting nitric oxide. J. Immunol. 159:1997;5585-5593.
41. De Caterina R., Libby P., Peng H. B., Thannickal V. J., Rajavashisth T. B., Gimbrone M. A. J., Shin W. S., Liao J. K. Nitric oxide decreases cytokine-induced endothelial cell activation: Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96:1995;60-68.
42. Peng H. B., Libby P., Liao J. K. Induction and stabilization of IκBα by nitric oxide mediates inhibition of NFκB. J. Biol. Chem. 270:1995;14214-14219.
43. Fahey T. J. III, Tracey K. J., Tekamp-Olson P., Cousens L. S., Jones W. G., Shires G. T., Cerami A., Sherry B. Macrophage inflammatory protein-1 modulates macrophage function. J. Immunol. 148:1992;2764-2769.
44. Kunkel S. L., Lukacs N. W., Strieter R. M. Chemokines and their role in human disease. Agents Actions. 46:1995;11-17.
45. Gl. J. Immunol. 159:1997;5063-5069.
46. Chensue S. W., Warmington K. S., Ruth J. H., Sanghi P. S., Lincoln P., Kunkel S. L. Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: Relationship to local inflammation, Th cell expression, and IL-12 production. J. Immunol. 157:1996;4602-4608.
47. Taub D. D., Oppenheim J. J. Chemokines, inflammation and the immune system. Ther. Immunol. 1:1994;229-246.
48. Marfaing-Koka A., Devergne O., Gorgone G., Portier A., Schall T. J., Galanaud P., Emilie D. J. Regulation of the production of RANTES chemokine by endothelial cells: Synergistic induction by IFN-γ plus TNF-α and inhibition by IL-4 and IL-13. J. Immunol. 154:1995;1870-1875.